Results
37
High return on equity, past performance and sound balance sheet.
37 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
DCBO | CA$66.39 | -4.9% | -2.0% | CA$2.0b | CA$75.69 | PE79.6x | E38.7% | n/a | Software | ||
LIF | CA$29.25 | 1.2% | -8.3% | CA$1.9b | CA$32.67 | PE9.6x | E-1.7% | 8.7% | Materials | ||
LUG | CA$31.85 | 4.8% | 110.1% | CA$7.6b | CA$34.50 | PE17.8x | E21.4% | 3.5% | Materials | ||
BDT | CA$29.39 | 5.0% | 149.3% | CA$1.6b | CA$34.44 | PE17.8x | E27.3% | 2.9% | Capital Goods | ||
CEU | CA$9.00 | 0.2% | 157.9% | CA$2.0b | CA$10.88 | PE10.3x | E5.6% | 1.3% | Energy | ||
CLS | CA$121.18 | 5.4% | 232.5% | CA$14.1b | CA$125.91 | PE26.8x | E13.6% | n/a | Tech | ||
CAF | CA$0.32 | -1.5% | 77.8% | CA$15.2m | n/a | PE6.4x | n/a | n/a | Materials | ||
MKZ.UN | CA$0.47 | 5.6% | 19.0% | CA$2.9m | n/a | PE5.7x | n/a | 17.5% | Diversified Financials | ||
AFM | CA$1.20 | -1.6% | 41.2% | CA$1.5b | n/a | PE15x | n/a | 10.2% | Materials | ||
BRM | CA$2.90 | -6.1% | 241.2% | CA$46.1m | n/a | PE8.9x | n/a | n/a | Commercial Services | ||
EPL | CA$0.095 | 11.8% | -20.8% | CA$10.9m | n/a | PE1.7x | n/a | n/a | Materials | ||
HWX | CA$7.02 | 4.5% | -1.8% | CA$1.7b | CA$9.39 | PE9x | E-11.6% | 5.7% | Energy | ||
OCI | CA$0.065 | 0% | 116.7% | CA$16.1m | n/a | PE2.2x | n/a | n/a | Materials | ||
SES | CA$16.77 | 0.7% | 117.8% | CA$4.0b | CA$17.68 | PE6.5x | E-34.6% | 2.4% | Energy | ||
NCI New | CA$1.19 | 8.2% | 580.0% | CA$50.2m | n/a | PE8.9x | n/a | n/a | Software | ||
HME | CA$1.82 | -0.5% | 44.4% | CA$178.0m | CA$2.60 | PE6x | E-11.6% | 8.8% | Energy | ||
TGH | CA$1.07 | 0.9% | 132.6% | CA$147.2m | CA$1.50 | PE12.8x | S21.0% | n/a | Capital Goods | ||
IBT | CA$1.44 | 0% | 73.5% | CA$35.3m | n/a | PE8.9x | n/a | n/a | Pharmaceuticals & Biotech | ||
MKO | CA$3.06 | 3.0% | 58.5% | CA$242.1m | n/a | PE7.8x | n/a | n/a | Materials | ||
CTZ | CA$1.09 | -3.5% | 17.2% | CA$29.3m | n/a | PE14.7x | n/a | 4.6% | Software | ||
RX | CA$10.91 | -1.7% | 30.7% | CA$126.5m | CA$11.75 | PE17.7x | S12.0% | 1.6% | Pharmaceuticals & Biotech | ||
SMAR.P | CA$0.01 | 0% | -50.0% | CA$158.0k | n/a | PE1.3x | n/a | n/a | Diversified Financials | ||
NIR.H | CA$0.02 | 0% | -93.3% | CA$545.3k | n/a | PE0.3x | n/a | n/a | Software | ||
DR | CA$15.73 | 4.4% | 81.2% | CA$369.6m | CA$16.30 | PE13.6x | E-30.0% | 2.3% | Healthcare |